Improving IR Spectroscopy as a Tool for Biopharmaceutical Analysis

Robert Kneschke/stock.adobe.com

Over the past two decades, the biopharmaceutical industry, along with the associated regulatory authorities and analytical instrument suppliers, have progressed toward clearer identification of the attributes that are critical for ensuring the quality of biopharmaceuticals and how to measure them efficiently.

The need to understand and predict these molecules’ behavior drives a requirement for new informational insights. This article puts the spotlight on infrared spectroscopy and recent innovations, including the introduction of Microfluidic Modulation Spectroscopy.

Read this article in BioPharm International’s July 2021 Biopharmaceutical Analysis eBook.

About the authors

Holly Lombardo*, HLombardo@redshiftbio.com, is product manager, and Matthew McGann is marketing manager; both are at RedShiftBio.

*To whom all correspondence should be addressed.

Article Details

BioPharm International
eBook: Biopharmaceutical Analysis, July 2021
July 2021
Pages: 31–34

Citation

When referring to this article, please cite it as H. Lombardo and M. McGann, “Improving IR Spectroscopy as a Tool for Biopharmaceutical Analysis," BioPharm International Biopharmaceutical Analysis eBook (July 2021).